Pharmaxis Ltd ADR (PXSLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2013 | 06-2012 | 06-2011 | 06-2010 | 06-2009 | |
| Sales | 3,320 | 1,370 | 0 | 730 | 100 |
| Cost of Goods | 1,170 | 530 | N/A | 270 | 20 |
| Gross Profit | 2,150 | 830 | N/A | 450 | 80 |
| Operating Expenses | 50,880 | 47,690 | 0 | 44,830 | 9,080 |
| Operating Income | -48,560 | -46,320 | N/A | -44,100 | -8,980 |
| Other Income | 3,840 | 6,340 | 0 | 3,260 | 670 |
| Pre-tax Income | -44,720 | -39,980 | 0 | -40,840 | -8,310 |
| Income Tax | 2 | -70 | N/A | 40 | 10 |
| Net Income Continuous | -42,990 | -39,908 | N/A | -40,886 | -26,308 |
| Net Income | $-44,720 | $-39,900 | $N/A | $-40,880 | $-8,330 |
| EPS Basic Total Ops | -2.17 | -2.20 | N/A | -2.78 | -2.10 |
| EPS Basic Continuous Ops | -2.09 | -2.20 | N/A | -2.78 | -2.10 |
| EPS Diluted Total Ops | -2.17 | -2.20 | N/A | -2.78 | -2.10 |
| EPS Diluted Continuous Ops | -2.09 | -2.20 | N/A | -2.78 | -2.10 |
| EBITDA(a) | $-43,860 | $-41,260 | $N/A | $-41,440 | $-8,980 |